<DOC>
	<DOCNO>NCT02897037</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety bivalirudin AMI patient DES . This prospective , randomize , single-blind , active drug control multicenter clinical research study would enrol total 380 AMI patient undergo percutaneous coronary intervention ( PCI ) one two antithrombotic regimen : bivalirudin alone , unfractionated heparin alone . All enrolled patient would followed-up 30 day .</brief_summary>
	<brief_title>Bivalirudin Acute Myocardial Infarction</brief_title>
	<detailed_description>This prospective , randomize , single-blind , active drug control multicenter clinical research study would enrol total 380 AMI patient undergo percutaneous coronary intervention ( PCI ) one two antithrombotic regimen : bivalirudin alone , unfractionated heparin alone . All enrolled patient would followed-up 30 day . The purpose study evaluate efficacy safety bivalirudin AMI patient DES .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Bivalirudin</mesh_term>
	<mesh_term>Hirudins</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>1 . Age 18 80 year old 2 . Planned emergency PCI acute myocardial infarction ( STEMI ) Symptom onset within 12h STEMI ( within 1224 hr patient unrelieved chest pain , continuous ST elevation new develop LBBB ) 3 . Provide write informed consent . 1 . Age &lt; 18 &gt; 80 year . 2 . Any anticoagulant drug regularly use within 3 month . 3 . Any anticoagulant agent use 48 h randomization . 4 . Active bleed bleed constitution , bleed tendency , include recent retina vitreous hemorrhage ( 1 month ) , GI urinary tract hemorrhage ( 3 month ) , cerebral hemorrhage ( 6 month ) cerebral infarction history ( 3 month ) , etc . 5 . Hemoglobin &lt; 90 g/L platelet count &lt; 100 * 109 / L. 6 . Untreated uncontrolled hypertension &gt; 180/110 mmHg . 7 . Elevated ALT level high three time normal upper limit ; severe renal insufficiency ( eGFR &lt; 30 mL/min / 1.73 m2 ) . 8 . Heparin induce thrombocytopenia . 9 . Suspicious aortic dissection , pericarditis subacute bacterial endocarditis . 10 . Known allergy study drug instrument ( UFH , bivalirudin , aspirin clopidogrel , stainless steel , contrast agent , etc . ) , allergic constitution . 11 . Pregnancy , lactation plan pregnant . 12 . Known serious progressive disease malignant tumor prognosis patient severe failure ; survival time &lt; 6 month . 13 . Unsuitable PCI . 14 . Attended clinical trial 1 month randomise .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Bivalirudin</keyword>
	<keyword>Acute myocardial infarction</keyword>
	<keyword>percutaneous transluminal coronary angioplasty</keyword>
</DOC>